Indy Hematology Review

http://www.indyhematologyreview.com/

 

Indy Hematology Review
Avatar

Risk Assessment and Genetic Mutations in MDS

By Indy Hematology Review FEATURING Richard Stone
By Indy Hematology Review FEATURING Richard Stone
0 views
June 26, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Indy Hematology Review 2019 Conference
25:01
Indy Hematology Review

Review of Emerging Therapies and Top Trials in Hematologic Malignanc…

Feat. R. Birhiray
20:17
Indy Hematology Review

Therapy for Newly Diagnosed Myeloma - Role of Transplant and MRD, DA…

Feat. K. Anderson
07:23
Indy Hematology Review

Novel Immune Therapies in Myeloma: BCMA Immunotoxin, Bites, and CAR …

Feat. K. Anderson
06:12
Indy Hematology Review

Targeting Mutations in Myeloma with Venetoclax and Development of th…

Feat. K. Anderson
21:06
Indy Hematology Review

Waldenström's Macroglobulinemia - Novel Therapeutic Approaches …

Feat. S. Treon
14:53
Indy Hematology Review

Treating CLL in 2019: Chemoimmunotherapy is Superior to Chemotherapy…

Feat. J. Woyach
11:19
Indy Hematology Review

CLL: Should Anyone Still be Treated with Chemoimmunotherapy, Improvi…

Feat. J. Woyach
14:46
Indy Hematology Review

Treatment of Follicular Lymphoma and Other Indolent Lymphomas: Is Ta…

Feat. B. Cheson
11:53
Indy Hematology Review

Hodgkin Lymphoma - Revolutionized Treatment Options Using Brentuxima…

Feat. B. Cheson
16:17
Indy Hematology Review

Treatment and New Trials in DLBCL - Modifications to R-CHOP Based on…

Feat. J. Leonard
05:14
Indy Hematology Review

Axi cell CAR T-cell Therapy for Refractory DLBCL - Overview of ZUMA-…

Feat. J. Leonard
11:24
Indy Hematology Review

Brentuximab Vedotin for Previously Untreated Peripheral T-cell Lymph…

Feat. J. Leonard
14:12
Indy Hematology Review

Immune Thrombocytopenic Purpura (ITP) - Immunopathogenesis, New ASH …

Feat. C. Kessler
21:15
Indy Hematology Review

Pharmacological Landscape of the Direct Oral Anticoagulants - Overvi…

Feat. C. Kessler
08:53
Indy Hematology Review

Follicular Lymphoma Chemo Treatment Regimens - Chemoimmunotherapy, R…

Feat. P. Zinzani
22:51
Indy Hematology Review

Chemo-free Regimens in Follicular Lymphoma

Feat. P. Zinzani
18:48
Indy Hematology Review

Starting Therapy in CML - Imatinib Treatment, Early Molecular Respon…

Feat. R. Larson
16:19
Indy Hematology Review

CML Treatment - Investigational Agents, Reducing Dosage to Reduce Si…

Feat. R. Larson
27:00
Indy Hematology Review

Acute Myeloid Leukemia - Overview of Available Novel Agents with Uni…

Feat. M. Tallman
07:47
Indy Hematology Review

Risk Assessment and Genetic Mutations in MDS

Feat. R. Stone
08:02
Indy Hematology Review

Are There New Approaches in Lower Risk MDS? Overview of Lenalidomide…

Feat. R. Stone
14:27
Indy Hematology Review

Treatment of High Risk MDS: Azacitidine Trials, Immune Checkpoint In…

Feat. R. Stone
19:10
Indy Hematology Review

Allo HSCT: Improvements in Transplant Outcomes, Myeloablative Vs. Re…

Feat. R. Childs
11:18
Indy Hematology Review

Relapse After Allo HSCT - Treatment Strategies and Overview of Relat…

Feat. R. Childs
17:35
Indy Hematology Review

Hematopoietic Stem Cell Transplantation: Types of Transplant, Compli…

Feat. R. Childs
08:31
Indy Hematology Review

Art Therapy and Patients With Cancer: Healing Through Creativity

Feat. M. Wiggins
10:17
Indy Hematology Review

Severe Aplastic Anemia: Diagnosis & First Line and Refractory Di…

Feat. R. Brodsky
06:09
Indy Hematology Review

Paroxysmal Nocturnal Hemoglobinuria (PNH) - Biology, Pathogenesis, E…

Feat. R. Brodsky
09:02
Indy Hematology Review

Molecular Anatomy of MPNs, Scoring Systems & Prognostic Scoring …

Feat. A. Fleischman
16:35
Indy Hematology Review

Review of ASH MPN Therapies: Pegylated Interferon vs. Hydroxyurea &a…

Feat. A. Fleischman
23:01
Indy Hematology Review

Improvements in Treating Ph-like ALL, Trials in Pre B-ALL & Blin…

Feat. H. Kantarjian
11:11
Indy Hematology Review

Immuno-oncology in ALL - Salvage Standard of Care, Mini-HCVD Plus In…

Feat. H. Kantarjian